This website is intended for US healthcare professionals only.

  • Contact Us
    • Contact BioCryst
    • Submit an Inquiry
    • Request a Grant or Sponsorship
    • Expanded-Access Program
  • Search Medical Information
BioCryst logo
  • Clinical Trials
  • Congresses
  • Publications
  • Disease State Information & Resources
    • Hereditary Angioedema (HAE)
    • Netherton Syndrome (NS)
    • Diabetic Macular Edema (DME)
    • Complement-Mediated Diseases
BioCryst logo
  • BioCryst logo
  • Clinical Trials
  • Congresses
  • Publications
    • Hereditary Angioedema (HAE)
    • Netherton Syndrome (NS)
    • Diabetic Macular Edema (DME)
    • Complement-Mediated Diseases
    • Contact BioCryst
    • Submit an Inquiry
    • Request a Grant or Sponsorship
    • Expanded-Access Program
  • Search Medical Information
  • Hereditary Angioedema Patients Would Prefer Newer-Generation Oral Prophylaxis

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
BioCryst logo

2025 BioCryst Pharmaceuticals, Inc.
All Rights Reserved

  • Contact Us
  • Terms of Use
  • Privacy Notice
  • Site Map
Close

You are now leaving biocrystmedical.com.

BioCryst is not responsible for and has no control over the content of linked sites.

Stay on Site Continue

This website is intended for healthcare professionals practicing in the US.

Are you a US healthcare professional? If not, you will be redirected to biocryst.com.

No, I am not a US healthcare professional Yes, I am a US healthcare professional